On May 2, 2021 Cytocom, Inc., a leading biopharmaceutical company creating second generation immune therapies, reported that Mike Handley, President and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference taking place March 9, 2021 to March 10, 2021 (Press release, Cytocom, MAR 2, 2021, https://www.cytocom.com/2021/03/02/cytocom-to-present-at-the-h-c-wainwright-global-life-sciences-conference/?utm_source=rss&utm_medium=rss&utm_campaign=cytocom-to-present-at-the-h-c-wainwright-global-life-sciences-conference [SID1234575924]). The presentation will be available on demand during the virtual event for all registered attendees.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
During the presentation, Mr. Handley will provide an overview of Cytocom’s business and recent corporate achievements, as well as the anticipated milestones in its clinical programs for COVID-19, pancreatic cancer, Crohn’s disease, fibromyalgia and multiple sclerosis.
Details of the events are as follows:
Event: H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021 to Wednesday, March 10, 2021
Time: Available on Demand
Registration: View Source
Members of the Cytocom’s management team will also be available to participate in virtual one-on-one meetings with investors who are registered to attend the conference. Following the conclusion of the event, a recording of Mr. Handley’s presentation will be available under "Recent Presentations" in the Investors section of the Company’s website at www.cytocom.com.